Aigen Investment Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Aigen Investment Management’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,711	Closed	-$414K	–	707
2021 Q2	$414K	Sell	9,711 -2,687	-22%	-$105K	0.07%	266
2021 Q1	$475K	Sell	12,398 -6,631	-35%	-$282K	0.06%	297
2020 Q4	$833K	Sell	19,029 -30,093	-61%	-$1.13M	0.11%	247
2020 Q3	$1.93M	Buy	+49,122	New	+$1.59M	0.25%	117
2020 Q2	–	Sell	-8	Closed	–	–	1392
2020 Q1	$0	Sell	8 -4,151	-100%	-$175K	﹤0.01%	1655
2019 Q4	$202K	Buy	+4,159	New	+$189K	0.03%	550

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aigen Investment Management's CSII Position: Q3 2021 in Review

Aigen Investment Management sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2021, closing a stake of 9,711 shares — an estimated $414K sold.

Aigen Investment Management first reported a position in CSII in Q4 2019 and held it in 6 quarters. The position peaked at $1.93M in Q3 2020. 171 funds tracked by Wall St. Rank hold CSII as of Q3 2021.

Aigen Investment Management reported no remaining Cardiovascular Systems, Inc. position as of Q3 2021 after selling out during the quarter.
Aigen Investment Management sold 9,711 Cardiovascular Systems, Inc. shares in Q3 2021, an estimated $414K.
Aigen Investment Management first reported a position in Cardiovascular Systems, Inc. in Q4 2019 and held it in 6 quarters.
Aigen Investment Management's Cardiovascular Systems, Inc. position peaked at $1.93M in Q3 2020.
171 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2021.

Based on Aigen Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.